Compare Illumina, Inc. (ILMN) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs AT&T Inc. — how do they compare? Illumina, Inc. trades at $191.61 (market cap $27.94B), while AT&T Inc. trades at $22.08 (market cap $152.52B). The key difference: AT&T Inc. is far larger — about 5.5× Illumina, Inc.'s market cap, and AT&T Inc. pays a 5.06% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | T | |
|---|---|---|
Market Cap | $27.94B | $152.52B |
Sector | Health | Media |
52-Week High | $194.33 | $29.62 |
52-Week Low | $91.00 | $20.49 |
Enterprise Value | $29.33B | $297.87B |
Dividend Yield | — | 5.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
AT&T (T) trades at $21.91, up 0.52% today, with a bullish technical signal and strong fundamentals including a 17.47% net income margin and consistent earnings beats. The stock shows improving cash flow trends, with net cash flow turning positive to $15.12B in 2025. Recent news highlights fiber expansion and competitive threats from Starlink, while analyst consensus leans toward a buy with a $26.18 price target.
The outlook is cautiously optimistic given attractive valuation multiples like a P/E of 7.34 and a 19.95% ROE, but risks include intense telecom competition and debt levels. The stock offers a dividend yield supported by sustainable cash flows, positioning it as a value play with moderate growth potential amid industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
